Evidence map›Paper›PMID 38140632›Full record

ArticleViruses2023

Phylogenetic Analysis of Hepatitis C Virus Infections in a Large Belgian Cohort Using Next-Generation Sequencing of Full-Length Genomes.

Kasper T Christensen, Florian Pierard, David Bonsall, Rory Bowden, Eleanor Barnes, Eric Florence, M Azim Ansari, Dung Nguyen, Mariateresa de Cesare, Frederik Nevens and 9 more

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 66% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 3 countries.

Kasper T ChristensenLaboratory of Clinical and Epidemiological Virology, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, 3000 Leuven, Belgium.
Florian PierardLaboratory of Clinical and Epidemiological Virology, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, 3000 Leuven, Belgium.
David BonsallBig Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7LF, UK.
Rory BowdenThe Wellcome Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK.
Eleanor BarnesPeter Medawar Building for Pathogen Research, University of Oxford, Oxford OX1 3SY, UK.
Eric FlorenceDepartment of General Internal Medicine, Infectious Diseases and Tropical Medicine, Antwerp University Hospital, 2650 Edegem, Belgium.
M Azim AnsariNuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK.
Dung NguyenThe Wellcome Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK.
Mariateresa de CesareThe Wellcome Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK.
Frederik NevensDepartment of Gastroenterology and Hepatology, University Hospitals Leuven, 3000 Leuven, Belgium.
Geert RobaeysDepartment of Gastroenterology and Hepatology, University Hospitals Leuven, 3000 Leuven, Belgium.
Yoeri SchrootenLaboratory of Clinical and Epidemiological Virology, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, 3000 Leuven, Belgium.
Dana BusschotsFaculty of Medicine and Life Sciences-LCRC, UHasselt, Agoralaan, 3590 Diepenbeek, Belgium.ORCID 0000-0003-0887-4119
Peter SimmondsHenry Wellcome Building for Molecular Physiology, Nuffield Department of Medicine, University of Oxford, Old Road Campus, Headington, Oxford OX3 7BN, UK.ORCID 0000-0002-7964-4700
Anne-Mieke VandammeLaboratory of Clinical and Epidemiological Virology, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-6594-2766
Eric Van WijngaerdenDepartment of General Internal Medicine, University Hospitals Leuven, 3000 Leuven, Belgium.
Tim DierckxLaboratory of Clinical and Epidemiological Virology, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-1969-7974
Lize CuypersLaboratory of Clinical and Epidemiological Virology, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-9433-8752
Kristel Van LaethemLaboratory of Clinical and Epidemiological Virology, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0001-6036-2271
Rega Institute for Medical Research · BECentre for Human Genetics · GBUniversity of Oxford · GBKU Leuven · BEZiekenhuis Oost-Limburg · BEAntwerp University Hospital · BE

Funding

Medical Research Council MR/K01532X/1Wellcome Trust
6 · The paper itself

Abstract

The hepatitis C virus (HCV) epidemic in Western countries is primarily perpetuated by the sub-populations of men who have sex with men (MSM) and people who inject drugs (PWID). Understanding the dynamics of transmission in these communities is crucial for removing the remaining hurdles towards HCV elimination. We sequenced 269 annotated HCV plasma samples using probe enrichment and next-generation sequencing, obtaining 224 open reading frames of HCV (OR497849-OR498072). Maximum likelihood phylogenies were generated on the four most prevalent subtypes in this study (HCV1a, 1b, 3a, 4d) with a subsequent transmission cluster analysis. The highest rate of clustering was observed for HCV4d samples (13/17 (76.47%)). The second highest rate of clustering was observed in HCV1a samples (42/78 (53.85%)) with significant association with HIV-positive MSM. HCV1b and HCV3a had very low rates of clustering (2/83 (2.41%) and (0/29)). The spread of the prevalent subtype HCV1b appears to have been largely curtailed, and we demonstrate the onwards transmission of HCV1a and HCV4d in the HIV-positive MSM population across municipal borders. More systematic data collection and sequencing is needed to allow a better understanding of the HCV transmission among the community of PWID and overcome the remaining barriers for HCV elimination in Belgium.

Indexed as

Hepatitis CHIV InfectionsHIV SeropositivitySexual and Gender MinoritiesSubstance Abuse, IntravenousBelgiumHepacivirusHigh-Throughput Nucleotide SequencingHomosexuality, MaleHumansMalePhylogenyfull-genome sequencinghepatitis chuman immunodeficiency virusmen who have sex with mennext-generation sequencingpeople who inject drugsphylogenetic analysis

Identifiers

PMID38140632
PMCPMC10747466
OpenAlexW4389485920

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.